FEI Legal: Positive Medication Case
The analysis of the urine sample collected from the horse Orkara at the FEI Open European Championship which took place in Compiègne (FRA) on 26 August 2005 revealed the presence of Guanabenz and its metabolite Hydroxy-Guanabenz, which are prohibited substances under FEI rules. The confirmatory analysis requested by the Person Responsible, Sheik Majid Mohd Al Maktoum, confirmed the presence of the above substances.
The Person Responsible has been requested to submit his explanation as to the presence of the prohibited substance and any relevant evidence to be taken into consideration by the FEI Judicial Committee by 9 January 2006.
Note to the editor
Sheik Majid bin Mohd Al Maktoum / Orkara were placed 3rd individually in the FEI European Open Championship and were part of the Open category winning UAE Team.
Guanabenz is a long active reversible sedative and analgesic. The substance is used in humans to lower blood pressure and decrease heart rate. The substance is graded ?1? by the FEI Medication sub-committee (1 = high potential to affect performance).
The Laboratoire des Courses Hippiques (LCH) issued its analysis report with respect to the A Sample on 26 September 2005 and the Racing Laboratory of the Hong Kong Jockey Club (HKJC) issued its analysis report with respect to the B Sample on 20 November 2005.
The list of prohibited substances for horses is published on the FEI website www.horsesport.org section Veterinary ? medication control. The FEI complete legal procedure for positive medication cases is published in the Legal section of the FEI website
FEI Web Site